Exane Derivatives P Lx Pharma Inc. Transaction History
Exane Derivatives
- $157 Million
- Q2 2022
A detailed history of Exane Derivatives transactions in P Lx Pharma Inc. stock. As of the latest transaction made, Exane Derivatives holds 6,575 shares of PLXP stock, worth $0. This represents 0.01% of its overall portfolio holdings.
Number of Shares
6,575
Previous 13,407
50.96%
Holding current value
$0
Previous $54,000
72.22%
% of portfolio
0.01%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding PLXP
# of Institutions
6Shares Held
62.7KCall Options Held
0Put Options Held
0-
Eidelman Virant Capital27KShares$00.01% of portfolio
-
O'Brien Greene & Co. Inc Media, PA27KShares$00.0% of portfolio
-
Financial Gravity Asset Management, Inc.1.05KShares$00.0% of portfolio
-
Financial Gravity Companies, Inc. Lakeway, TX1.05KShares$00.0% of portfolio
-
Tucker Asset Management LLC Littleton, CO25Shares$00.0% of portfolio
About PLx Pharma Inc.
- Ticker PLXP
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 29,137,700
- Description
- PLx Pharma Inc. operates as a commercial-stage drug delivery platform technology company in the United States. The company's lead product candidates are Vazalore 325 mg for the patients with vascular events, such as heart attacks and clot-related strokes, as well as for use in conditions associated with pain and inflammation, including other asp...